Filing Details

Accession Number:
Form Type:
Zero Holdings:
Publication Time:
2014-05-15 14:42:20
Reporting Period:
Filing Date:
Accepted Time:
2014-05-15 14:42:20
SEC Url:
Form 4 Filing
Cik Name Symbol Sector (SIC) IRS No
912183 Cubist Pharmaceuticals Inc CBST Pharmaceutical Preparations (2834) 223192085
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1219016 W Michael Bonney 65 Hayden Avenue
Lexington MA 02421
Chief Executive Officer Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2014-05-14 6,250 $0.00 178,895 No 4 M Direct
Common Stock Disposition 2014-05-15 3,036 $67.50 175,859 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Restricted Stock Units Disposition 2014-05-14 6,250 $0.00 6,250 $0.00
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2014-05-14 No 4 M Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 6,816 Indirect 401(k) Plan
Common Stock 600 Indirect Trusts
  1. Sold pursuant to a 10(b)5-1 Plan
  2. Shares were sold to cover tax withholding obligations incurred in connection with the vesting of Restricted Stock Units.
  3. Each restricted stock unit represents a contingent right to receive one share of Cubist common stock for no consideration.
  4. The restricted stock units vest 25% annually over a four-year period, with the first 25% vesting one year after the grant date. The restricted stock units do not expire.